Cargando…

Biosynthetic Potential of Streptomyces Rationalizes Genome-Based Bioprospecting

Streptomyces are the most prolific source of structurally diverse microbial natural products. Advancing genome-based analysis reveals the previously unseen potential of Streptomyces to produce numerous novel secondary metabolites, which allows us to take natural product discovery to the next phase....

Descripción completa

Detalles Bibliográficos
Autores principales: Cibichakravarthy, Balasubramanian, Jose, Polapass Arul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300671/
https://www.ncbi.nlm.nih.gov/pubmed/34356794
http://dx.doi.org/10.3390/antibiotics10070873
_version_ 1783726503522992128
author Cibichakravarthy, Balasubramanian
Jose, Polapass Arul
author_facet Cibichakravarthy, Balasubramanian
Jose, Polapass Arul
author_sort Cibichakravarthy, Balasubramanian
collection PubMed
description Streptomyces are the most prolific source of structurally diverse microbial natural products. Advancing genome-based analysis reveals the previously unseen potential of Streptomyces to produce numerous novel secondary metabolites, which allows us to take natural product discovery to the next phase. However, at present there is a huge disproportion between the rate of genome reports and discovery of new compounds. From this perspective of harnessing the enduring importance of Streptomyces, we discuss the recent genome-directed advancements inspired by hidden biosynthetic wealth that provide hope for future antibiotics.
format Online
Article
Text
id pubmed-8300671
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83006712021-07-24 Biosynthetic Potential of Streptomyces Rationalizes Genome-Based Bioprospecting Cibichakravarthy, Balasubramanian Jose, Polapass Arul Antibiotics (Basel) Perspective Streptomyces are the most prolific source of structurally diverse microbial natural products. Advancing genome-based analysis reveals the previously unseen potential of Streptomyces to produce numerous novel secondary metabolites, which allows us to take natural product discovery to the next phase. However, at present there is a huge disproportion between the rate of genome reports and discovery of new compounds. From this perspective of harnessing the enduring importance of Streptomyces, we discuss the recent genome-directed advancements inspired by hidden biosynthetic wealth that provide hope for future antibiotics. MDPI 2021-07-19 /pmc/articles/PMC8300671/ /pubmed/34356794 http://dx.doi.org/10.3390/antibiotics10070873 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Perspective
Cibichakravarthy, Balasubramanian
Jose, Polapass Arul
Biosynthetic Potential of Streptomyces Rationalizes Genome-Based Bioprospecting
title Biosynthetic Potential of Streptomyces Rationalizes Genome-Based Bioprospecting
title_full Biosynthetic Potential of Streptomyces Rationalizes Genome-Based Bioprospecting
title_fullStr Biosynthetic Potential of Streptomyces Rationalizes Genome-Based Bioprospecting
title_full_unstemmed Biosynthetic Potential of Streptomyces Rationalizes Genome-Based Bioprospecting
title_short Biosynthetic Potential of Streptomyces Rationalizes Genome-Based Bioprospecting
title_sort biosynthetic potential of streptomyces rationalizes genome-based bioprospecting
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300671/
https://www.ncbi.nlm.nih.gov/pubmed/34356794
http://dx.doi.org/10.3390/antibiotics10070873
work_keys_str_mv AT cibichakravarthybalasubramanian biosyntheticpotentialofstreptomycesrationalizesgenomebasedbioprospecting
AT josepolapassarul biosyntheticpotentialofstreptomycesrationalizesgenomebasedbioprospecting